© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Many of the things common in modern tablet manufacturing evolved from the needs of early pharmaceutical production, especially as companies looked for ways to improve how medicine gets delivered and processed. Sodium stearyl fumarate, which has roots reaching back to the surge of excipient development through the late 20th century, wasn’t developed just to act as another filler. The pharmaceutical field needed better ways to make tablets that didn't fall apart, stuck less to machines, and improved how drugs worked when taken by mouth. Only through a combination of chemistry advancements and practical production experience did manufacturers come to see that salts like sodium stearyl fumarate hold certain features that magnesium stearate, the long-held go-to, just couldn't offer. As regulations on pharmaceutical ingredients became more rigorous, industry turned even more toward excipients with cleaner, predictable profiles. This focus led to broader adoption and more investment into fumaric acid-derived materials through the last few decades.
Sodium stearyl fumarate serves mainly as a lubricant in oral dosage forms. Most people working in pharmaceutical labs can spot it by its white, powdery look—typical for excipients. Its main job is to help powders and granules move through machinery more easily during tablet production. By doing so, it helps prevent ingredients from sticking to tablet punches, which can save resources and maintain product consistency. Unlike other traditional tablet lubricants, it dissolves more easily in water, especially in formulations where fast disintegration makes a big difference. That quality earned it trust among those who deal with solid oral dose products designed for rapid release.
You won’t find sodium stearyl fumarate melting in a hot car—its melting point rests above everyday ambient temperatures. Chemically, it comes about by combining stearyl alcohol, fumaric acid, and sodium, giving it a taste of both soapiness and saltiness. The long hydrocarbon chain from stearyl offers slickness, but the fumarate section raises its water compatibility, setting it apart from other lubricants that often slow down drug release. Its particle size, flow properties, and moisture levels all play a role in how it behaves on the tablet press, making control in manufacturing a real issue for those chasing batch-to-batch consistency.
Labeling details can be complicated. Pharmacopeias—those big books that dictate ingredient standards for safety and effectiveness—list sodium stearyl fumarate with its own monograph. The United States Pharmacopeia, for instance, expects a certain purity, specific sodium and fumaric acid content, set levels of heavy metals, and minimal microbial contamination. Each bag or drum must carry clear batch numbers, expiration dates, and optimal storage conditions. Doing this follows global regulatory requirements and helps keep track during recalls or quality checks. The detailed paperwork also ensures traceability, which regulatory agencies require for every pharmaceutical ingredient.
Making sodium stearyl fumarate means more than just mixing ingredients. Manufacturers tend to start with saponification—reacting stearyl alcohol with fumaric acid in the presence of sodium hydroxide. This process forms the sodium salt, while tightly controlling temperature, pH, and reaction time so impurities stay low and the finished powder meets physical size requirements. Once the reaction runs its course, the resulting mass gets filtered, washed, and dried until it turns into the fine white powder recognized by industry workers. Modern quality assurance backs up every step; even tiny changes in reactant quality or process times can change lubricant performance later.
In regular use, sodium stearyl fumarate doesn’t kick off strange chemistry. It resists breakdown under standard tableting conditions, and it remains stable with most pharmaceutical actives—one of the key reasons tablet makers appreciate it. Over many years, excipient scientists tested reaction profiles by mixing it with acids, bases, and salts often found in medicines or supplements, finding it mostly inert except under the most extreme laboratory conditions. Efforts to modify its structure—say, using shorter or unsaturated stearyl chains—don’t produce the same balance of water compatibility and lubricity, which shows the chemical design works for its purpose.
Ask suppliers around the world, and you’ll run into a mix of names for this ingredient: Sodium stearyl fumarate, fumaric acid, stearyl alcohol sodium salt, Fumarod®, PRUV®, or just “SSF.” All these names point to roughly the same salt; proprietary blends only shift in minor qualities, such as particle size or moisture. Companies make sure to keep catalogs in line with international databases so there’s no confusion, especially for those exporting drugs to countries that insist on certain nomenclature. Only a handful of suppliers have reached true global recognition, which streamlines procurement for big pharmaceutical operations.
Those who use sodium stearyl fumarate in industrial settings pay close attention to occupational safety. The powder may not be classified as hazardous in most chemical databases, but staff still wear dust masks, gloves, and work under local ventilation. Skin and eye contact remain the main concerns, and accidental inhalation is best avoided. In house operations protocols require rigorous documentation of cleaning processes and material handling. Regulatory bodies worldwide have endorsed the ingredient at standard use levels in direct-contact pharmaceutical products, provided it falls within guideline purity limits and doesn’t carry allergenic contaminants. Food contact is less common, but in some countries, food authorities also approved its use as a processing aid.
Sodium stearyl fumarate turned into a key player in oral tablets—including prescription drugs, over-the-counter medicines, and some dietary supplements. Its rapid-dissolving nature makes it valuable for chewable tablets, orodispersible forms, and pediatric or geriatric meds where people sometimes struggle to swallow tablets whole. Nutrition product designers also look to it for new supplement formats; its stable profile fits with vitamins, minerals, and herbal extracts. Beyond pharma, interest in using the salt as a functional blend in fine chemicals and specialty powders keeps growing.
Laboratories dedicated to excipient tech often examine how sodium stearyl fumarate reacts in new formulations, exploring its behavior alongside traditional fillers, binders, and active pharmaceutical ingredients. Its impact on disintegration rates, dissolution speed, and overall bioavailability draws heavy scrutiny. Studies continue to compare its performance with tried-and-true lubricants like magnesium stearate, especially for high-speed, high-output tablet production. Pharmaceutical scientists work with particle engineering to reduce dusting, improve handling, and adapt the salt for continuous manufacturing lines, since these features become crucial for newer, flexible production setups.
Toxicology tests for sodium stearyl fumarate span cell line testing, rodent studies, and human clinical trials. Repeated assessments over years show negligible absorption through the gut, and little to no bioaccumulation. The salt breaks down into stearyl alcohol and fumaric acid derivatives, which the human body processes efficiently. Regulatory authorities from the US FDA, European Medicines Agency, and international health bodies accept it for use in regulated products due to these findings. Occasional reports detail minor irritation if large amounts get in the eyes or respiratory tract, though those incidents stem mostly from mishandling during large-scale manufacturing or bulk sampling. No evidence points to serious systemic toxicity, long-term health risks, or allergenic responses when kept at established usage amounts. Poison control calls regarding this ingredient remain extremely rare.
Pharmaceutical companies and excipient researchers continue tracking new trends where sodium stearyl fumarate may reach further. The rise of personalized medicine, with custom oral products and rapid, small-batch tablet manufacturing, creates a need for ingredients that support faster changeovers and cleaner processes. This lubricant’s water compatibility fits designs for rapid-dissolving products and conscious consumer brands who seek non-animal sourced, “clean label” components. Even as continuous manufacturing and smart tableting move to the forefront, sodium stearyl fumarate holds its spot because it adapts to high-shear mixers, compactors, and both direct compression and wet granulation methods. Academics keep testing blends for drugs with tricky solubility or stability, noting this salt’s contribution to consistent performance. Demand likely will expand as more start-ups and emerging-market manufacturers choose cost-effective, versatile formulations.
People often overlook the behind-the-scenes players that keep modern medicine moving. One of those quiet workhorses is sodium stearyl fumarate (SSF). It doesn’t sound exciting, but if you’ve ever swallowed a pill without it crumbling in your hand or jamming in your throat, you can thank ingredients like this. SSF gets mixed into tablets and capsules as what’s called a lubricant—helping powders flow together and come out of the machine ready to go. Every organized medicine cabinet has these sorts of ingredients just below the surface.
Decades ago, most tablet factories leaned heavily on magnesium stearate. Over time, problems crept up. That old standard sometimes slowed down how fast tablets fell apart in your stomach. Picture a painkiller that doesn’t work quickly enough just because it refuses to dissolve when you need it—frustrating, right? SSF landed in the spotlight as a fix for that. Studies show it won’t slow your pill down; the tablet stays strong during production, but breaks up on time after you swallow it.
I learned about SSF from a pharmacist friend always reading the fine print on drug labels. He pointed out how some patients with sensitive stomachs could manage their meds better thanks to smoother, faster-dissolving tablets. I never thought about what kept my daily vitamins from turning chalky. After looking up the science, I started checking ingredients myself.
SSF goes on the outside of tablet powders, acting like a little bit of oil on your hands when you roll out dough. Machines pack powders tightly enough to hold together, but SSF stops everything from sticking. In the past, companies struggled to keep tablets uniform in each batch. SSF brings consistency to the table—it helps those small factories with less advanced equipment chip in, not just giant pharmaceutical companies with endless budgets.
The chemical makeup gives SSF a stable nature, so pills don’t rot on a warm shelf or pick up strange flavors. Major safety agencies such as the FDA and the EMA have cleared it for use. This isn’t some niche laboratory experiment, but a workhorse found in plenty of trusted products.
SSF isn’t perfect. It costs a little more than old-school lubricants. Smaller manufacturers sometimes hesitate to change processes, especially if they’re comfortable. Consumer safety depends on honest labeling and responsible sourcing, since shortcuts in quality can affect patient health.
Experts warn that over time, any widely used additive deserves a closer look as science advances. Some researchers still check for rare allergic responses or review how the body metabolizes these things. In a world where people care more about every ingredient (think about gluten-free or allergen warnings), transparency drives trust. That means companies need to keep testing, keep publishing results, and upgrade their standards when evidence builds up.
The trusted pills and supplements in your drawer likely rely on a mix of modern chemicals developed for reliability and safety. SSF stands out as a smart pick where quality and speed both matter. Society benefits from small improvements like these—patients get better results, and pharmacists spend less time sorting out slow or unpredictable pills. In my experience, small tweaks almost always make a big difference when stakes are high. That’s where sodium stearyl fumarate earns its place on the label.
Walk through the aisles of any pharmacy or grocery store, and you’ll see ingredient names that look like they belong in a chemistry textbook. Sodium stearyl fumarate isn’t much different. It sounds technical, but it’s a compound used widely as a food additive and as a lubricant in medicines—especially tablets.
Tablets need to slide out of manufacturing equipment without sticking or crumbling. This is where sodium stearyl fumarate comes in. It helps tablets hold their shape and stops them from falling apart before you even get them out of the package. Food producers and pharmaceutical companies value how reliable it is.
Every so often, the spotlight lands on these additives, as people worry about long ingredient names. Parents, especially, want to know what goes into the snacks they give their kids or the pain reliever they keep on hand.
The U.S. Food and Drug Administration (FDA) maintains a list of ingredients considered safe to use in food and drugs. Sodium stearyl fumarate appears there. The European Food Safety Authority (EFSA) also reviewed its use and found no reason to raise alarms for the quantities used in food and medicine.
A handful of independent studies looked at toxicity and irritation, even when animals or cells got exposed to higher doses than what’s used in products. The outcomes: no toxic effects, no buildup in the body over time. It passes through the digestive system, doesn’t break down into harmful compounds, and doesn’t get stored. People with allergies, especially to related compounds, might still want to check labels carefully. For the vast majority of the population, there’s strong evidence that this substance won’t cause trouble.
Questions crop up about these compounds because the science isn’t familiar to most. A long name doesn’t always signal a big risk—sometimes it only means chemists have been involved and there’s a lot to explain. In my experience working with people nervous about medications, creating a space where questions about safety get answered by referencing trustworthy health authorities and research can go a long way. People want clarity, not chemistry class.
People trust labels. Still, more information on the package, or honest answers from pharmacists and doctors, can reassure someone worried about what they swallow. As food and drug development shifts to add more kinds of substances, keeping research transparent and making safety data public matters. Companies benefit when they publish results of testing, including rare side effects. When this kind of openness becomes the rule, we all get to make choices that fit our own health and comfort level.
If anxiety about additives persists, individuals have options. Some look for products with shorter ingredient lists, and there’s value in supporting a marketplace that lets consumers pick what feels right for them. Food safety watchdogs and independent researchers should keep tabs on emerging studies, making sure that safe today means safe a decade from now.
Not every scientific name on a label spells danger. In the case of sodium stearyl fumarate, major health regulators saw enough evidence of safety to allow its use. Instead of guessing, looking at what’s known—and who’s checking—gives reassurance and puts control back in the hands of regular people and their families.
Labels on medication or supplements often list ingredients in a long string of unfamiliar chemical names. Sodium stearyl fumarate (SSF) pops up on those labels, usually near the bottom. For many, just reading the name feels like reading a foreign language. If you're vegan or looking to avoid animal products, seeing these unpronounceable words triggers some real worry. Nobody wants to learn after the fact that their pain relief capsules weren't as plant-based as they expected.
Sodium stearyl fumarate usually comes from a reaction involving stearic acid and fumaric acid. The story about whether SSF counts as vegan hinges on where stearic acid enters the mix. Stearic acid can be pulled from animal fat, but big manufacturers have recognized a rising demand for plant origins. In many facilities, vegetable oils—palm and soybean take the lead—form the base for stearic acid. The shift to plant sources isn't just to save costs. Consumers are reading more labels, making their beliefs known with every purchase.
Supply chains aren’t always clear about their upstream sourcing. Every pharma or supplement company sources key ingredients like SSF through its own network of suppliers. Some publish their compliance standards or third-party certifications, especially for vegan or “animal-free” products. Drug companies have updated their practices over the years, but without full transparency, all bets are off. Even if a manufacturer claims a vegan supply, contract manufacturing sometimes leads to ingredient swaps without notice.
I remember combing through ingredient lists after switching to a plant-based diet. My biggest surprise: lots of “inert” ingredients—like excipients—come with a tangled history. Friends who work in pharmacy tell me the switch to plant-based excipients tracks closely with consumer demand and brand reputation. It’s not just about animal welfare; concerns about allergens, sustainability, and even faith-based dietary laws play a part. Cost and availability can sometimes tempt companies to cut ethical corners. It’s extra work for those who care enough to ask.
If you’re serious about finding out what goes into your medicines or supplements, start by asking manufacturers for documented sourcing. Many will respond, especially if they sense that clarity brings customer loyalty. Vegan certification bodies, such as The Vegan Society, audit supply chains to provide that added guarantee. If you don’t get the answers you want, switching to a better-documented or certified alternative product sends a message to companies that labels and sourcing matter a lot.
Reading the fine print and emailing customer service reps doesn’t always feel rewarding. But growing pressure influences supply chain decisions. Today, more companies are moving away from animal-sourced stearic acid, and sodium stearyl fumarate often comes from plant oils, thanks largely to the insistence of careful customers. Nobody else will check for you, so staying alert can shape what manufacturers put in the bottle.
Pharma companies spend a lot of time trying to get tablets to break apart at the right speed when swallowed. I’ve seen labs obsess over this, working to prevent patients from struggling with tablets that fall apart too fast or, on the flip side, refuse to break down at all. Sodium stearyl fumarate (SSF) shapes this process in ways other options can’t match. Unlike magnesium stearate, which often forms a greasy coating and slows things down, SSF keeps the powder blend airy. Doctors and patients benefit from tablets that dissolve at predictable rates, which supports proper uptake of the medicine without frustrating delays.
SSF brings some welcome peace to formulators grappling with compatibility issues. Some medicines, like basic antibiotics or vitamin blends, show stubborn streaks when you add magnesium stearate—the classic lubricant. SSF avoids forming unwanted chemical bonds. There’s less risk of reactions that could stir up allergies or destabilize active drugs. That matters to people with allergies and those taking multiple medications. Companies have validated this with stability testing in labs worldwide, confirming that sensitive ingredients stay true and undisturbed.
Ask any production manager about trouble on tablet lines, and the stories come pouring out: powder sticking to punches, tablets that crack at the slightest bump, or weights that drift outside specs. SSF improves the mechanical flow of powders as machines churn through thousands of units per hour. It gives manufacturers some breathing room, allowing better control of compressibility and reducing defects. Tablets punched from blends with SSF tend to hold together—cutting down on dust and troubleshooting calls from the shop floor. The numbers bear this out: Quality labs report higher yield percentages with less out-of-spec product, saving money and minimizing drug shortages in pharmacies.
GMP auditors don’t want surprises, and neither do the people on the line. SSF checks a lot of regulatory boxes without bringing unwelcome paperwork. It’s broadly accepted in the US, Europe, and other regions because of its established safety record. Formulators find it easier to justify SSF during inspection—studies published by regulatory bodies, like the European Medicines Agency, underline its low toxicity and lack of worrying impurities. Quality directors use this to steer clear of warning letters, which protects a company’s reputation and ensures patients keep getting clean, safe products.
The push for new drug delivery systems makes SSF even more valuable. Formulators designing slow-release or multi-layered tablets pick SSF because it plays well with modern excipients, including those in orally disintegrating forms. Its unique crystalline structure helps design more advanced pills that release drugs on schedule or melt in the mouth, meeting demands for convenience and patient comfort. Many innovations in pain management, antidepressants, and long-term therapies rest on excipients like SSF to get from the lab to pharmacy shelves.
Sometimes, excipients grab attention for causing problems, not solving them. Magnesium stearate, for instance, occasionally causes upset stomachs in sensitive individuals. SSF sidesteps those complaints—reports of adverse effects show up less often, especially among pediatric and geriatric patients whose bodies don’t bounce back from ingredient irritation. This reduces doctor callbacks and lets patients stick to their medication schedules.
SSF’s track record brings confidence both to caregivers and those of us who help develop new medications. Pharmaceutical standards evolve, and ingredients that prove themselves time and again—like SSF—become cornerstones rather than short-term fixes. By supporting reliable manufacturing, simplifying compliance, and ensuring safer choices for patients, SSF gives the industry room to solve tougher health challenges with fewer roadblocks.
Sodium stearyl fumarate, often tagged with the abbreviation SSF, slides quietly into the world of pharmaceutical tablets as a lubricant. Instead of grabbing headlines or sparking health debates, this white powder spends time improving tablet manufacturing. It helps powders flow and compress better, reducing the kind of sticking that turns a routine batch into a headache.
SSF’s reputation among pharmaceutical experts is plain and straightforward. Rigorous safety checks have covered it, earning an official thumbs-up from drug authorities in regions like the United States and Europe. SSF gets broken down in the gut into stearyl alcohol and fumaric acid—both of which pop up in food. You’ll find stearyl alcohol in skin creams, and fumaric acid even lands a spot as a food additive.
No flash floods of allergy complaints, no big red warning flags in reputable scientific journals, and no dramatic appearances on health watchdog blogs. Side effects in patients just haven’t popped up. Still, any chemical used in medicines can get its own chapter if a new health issue ever shows up, so researchers and drug makers keep it under regular review.
SSF does not land on most “allergy alert” lists. But people with a known allergy to stearyl alcohol or fumaric acid have a reason to check tablet ingredients before taking new medication. Chemists see SSF as a low-risk bet, and the amount per tablet rarely tops a few milligrams.
SSF isn’t sitting in the medicine cabinet looking for trouble. Scientists have tossed it into study after study alongside common drug types. Results have stayed boring: SSF doesn’t seem to cause trouble with other chemicals or vitamins inside a tablet. It just keeps tablets from sticking in machines, not in your body.
I searched for any reports linking SSF with drug reactions or changes in how medicines get absorbed; so far, there’s nothing noteworthy. Still, pharmacists argue for a cautious approach when patients manage multiple prescriptions. A rare reaction can always surprise, and a medicine full of excipients (the so-called “inactive” ingredients) can puzzle patients who track every detail.
Trust gets built by reading ingredient labels and asking questions, especially if you manage allergies or sensitivities. If you take several daily medications and react to a new prescription, tell your healthcare provider about every supplement and filler you swallow.
Doctors and pharmacists need real-world feedback, not just reports buried in academic journals. If a patient flags a possible side effect, even something mild, that report adds to the growing pool of safety data. Agencies like the FDA built their safety systems on people speaking up.
Drug labels could do a better job explaining what excipients like SSF actually are. Patients should not have to squint at tiny print and memorize chemical names. Straight answers from pharmacists help cut confusion. Healthcare systems could offer more readable breakdowns—even apps that let users check risks based on their personal allergy profiles.
Modern pharmacy relies on dozens of ingredients like SSF to make medication easier and safer to take. Trust grows out of clear facts, honest reporting, and an open line between patients, pharmacists, and the companies making our medicine. Sodium stearyl fumarate keeps a low profile, but patient curiosity keeps the conversation alive.
| Names | |
| Preferred IUPAC name | Sodium (E)-octadecoate-2-yl fumarate |
| Other names |
PRUV Stearyl fumarate sodium Sodium octadecyl fumarate |
| Pronunciation | /ˈsəʊdiəm ˈstiːrɪl fjuːˈmeɪrət/ |
| Identifiers | |
| CAS Number | 4070-80-8 |
| Beilstein Reference | 3923779 |
| ChEBI | CHEBI:53499 |
| ChEMBL | CHEMBL2108832 |
| ChemSpider | 26664852 |
| DrugBank | DB14162 |
| ECHA InfoCard | '03b5d82e-2bdb-47c1-aa70-c728621a0813' |
| EC Number | 293-405-1 |
| Gmelin Reference | 1946356 |
| KEGG | C14321 |
| MeSH | D000072612 |
| PubChem CID | 23665879 |
| RTECS number | WH8900000 |
| UNII | 7K435059DT |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | `DTXSID2020194` |
| Properties | |
| Chemical formula | C22H43NaO4 |
| Molar mass | 426.62 g/mol |
| Appearance | White or almost white, fine powder |
| Odor | Odorless |
| Density | 300 kg/m3 |
| Solubility in water | Insoluble |
| log P | -4.72 |
| Acidity (pKa) | 6.5 |
| Basicity (pKb) | pKb: 5.5 |
| Dipole moment | 1.7634 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 749.7 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | A07BC |
| Hazards | |
| Main hazards | May cause respiratory and eye irritation. |
| GHS labelling | GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | May cause respiratory irritation. |
| Precautionary statements | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention. |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | > 200°C |
| LD50 (median dose) | LD50 (median dose): >2000 mg/kg (rat, oral) |
| PEL (Permissible) | Not established |
| REL (Recommended) | 10 mg/m³ |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Stearyl fumarate Sodium fumarate Fumaric acid Sodium stearate |
